Global Influenza Treatment Market Research Report 2023

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Peramivir
1.2.3 Zanamivir
1.2.4 Baloxavir Marboxil
1.2.5 Oseltamivir Phosphate
1.2.6 Others
1.3 Market by Channel
1.3.1 Global Influenza Treatment Market Growth by Channel: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Treatment Market Perspective (2018-2029)
2.2 Influenza Treatment Growth Trends by Region
2.2.1 Global Influenza Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Influenza Treatment Historic Market Size by Region (2018-2023)
2.2.3 Influenza Treatment Forecasted Market Size by Region (2024-2029)
2.3 Influenza Treatment Market Dynamics
2.3.1 Influenza Treatment Industry Trends
2.3.2 Influenza Treatment Market Drivers
2.3.3 Influenza Treatment Market Challenges
2.3.4 Influenza Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Treatment Players by Revenue
3.1.1 Global Top Influenza Treatment Players by Revenue (2018-2023)
3.1.2 Global Influenza Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Treatment Revenue
3.4 Global Influenza Treatment Market Concentration Ratio
3.4.1 Global Influenza Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Treatment Revenue in 2022
3.5 Influenza Treatment Key Players Head office and Area Served
3.6 Key Players Influenza Treatment Product Solution and Service
3.7 Date of Enter into Influenza Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Treatment Breakdown Data by Type
4.1 Global Influenza Treatment Historic Market Size by Type (2018-2023)
4.2 Global Influenza Treatment Forecasted Market Size by Type (2024-2029)
5 Influenza Treatment Breakdown Data by Channel
5.1 Global Influenza Treatment Historic Market Size by Channel (2018-2023)
5.2 Global Influenza Treatment Forecasted Market Size by Channel (2024-2029)
6 North America
6.1 North America Influenza Treatment Market Size (2018-2029)
6.2 North America Influenza Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Influenza Treatment Market Size by Country (2018-2023)
6.4 North America Influenza Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Treatment Market Size (2018-2029)
7.2 Europe Influenza Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Influenza Treatment Market Size by Country (2018-2023)
7.4 Europe Influenza Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Treatment Market Size (2018-2029)
8.2 Asia-Pacific Influenza Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Influenza Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Influenza Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Treatment Market Size (2018-2029)
9.2 Latin America Influenza Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Influenza Treatment Market Size by Country (2018-2023)
9.4 Latin America Influenza Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Treatment Market Size (2018-2029)
10.2 Middle East & Africa Influenza Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Influenza Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Influenza Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Influenza Treatment Introduction
11.1.4 Novartis AG Revenue in Influenza Treatment Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 Roche Holding
11.2.1 Roche Holding Company Detail
11.2.2 Roche Holding Business Overview
11.2.3 Roche Holding Influenza Treatment Introduction
11.2.4 Roche Holding Revenue in Influenza Treatment Business (2018-2023)
11.2.5 Roche Holding Recent Development
11.3 BioCryst Pharmaceuticals
11.3.1 BioCryst Pharmaceuticals Company Detail
11.3.2 BioCryst Pharmaceuticals Business Overview
11.3.3 BioCryst Pharmaceuticals Influenza Treatment Introduction
11.3.4 BioCryst Pharmaceuticals Revenue in Influenza Treatment Business (2018-2023)
11.3.5 BioCryst Pharmaceuticals Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Influenza Treatment Introduction
11.4.4 Sanofi Revenue in Influenza Treatment Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 GSK plc.
11.5.1 GSK plc. Company Detail
11.5.2 GSK plc. Business Overview
11.5.3 GSK plc. Influenza Treatment Introduction
11.5.4 GSK plc. Revenue in Influenza Treatment Business (2018-2023)
11.5.5 GSK plc. Recent Development
11.6 Viatris Inc. (Mylan)
11.6.1 Viatris Inc. (Mylan) Company Detail
11.6.2 Viatris Inc. (Mylan) Business Overview
11.6.3 Viatris Inc. (Mylan) Influenza Treatment Introduction
11.6.4 Viatris Inc. (Mylan) Revenue in Influenza Treatment Business (2018-2023)
11.6.5 Viatris Inc. (Mylan) Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Influenza Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Influenza Treatment Business (2018-2023)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Detail
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Influenza Treatment Introduction
11.8.4 Daiichi Sankyo Revenue in Influenza Treatment Business (2018-2023)
11.8.5 Daiichi Sankyo Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Influenza Treatment Introduction
11.9.4 AstraZeneca Revenue in Influenza Treatment Business (2018-2023)
11.9.5 AstraZeneca Recent Development
11.10 NATCO Pharma Limited
11.10.1 NATCO Pharma Limited Company Detail
11.10.2 NATCO Pharma Limited Business Overview
11.10.3 NATCO Pharma Limited Influenza Treatment Introduction
11.10.4 NATCO Pharma Limited Revenue in Influenza Treatment Business (2018-2023)
11.10.5 NATCO Pharma Limited Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Detail
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Influenza Treatment Introduction
11.11.4 Gilead Sciences Revenue in Influenza Treatment Business (2018-2023)
11.11.5 Gilead Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Peramivir
Table 3. Key Players of Zanamivir
Table 4. Key Players of Baloxavir Marboxil
Table 5. Key Players of Oseltamivir Phosphate
Table 6. Key Players of Others
Table 7. Global Influenza Treatment Market Size Growth by Channel (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Influenza Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Influenza Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Influenza Treatment Market Share by Region (2018-2023)
Table 11. Global Influenza Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Influenza Treatment Market Share by Region (2024-2029)
Table 13. Influenza Treatment Market Trends
Table 14. Influenza Treatment Market Drivers
Table 15. Influenza Treatment Market Challenges
Table 16. Influenza Treatment Market Restraints
Table 17. Global Influenza Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Influenza Treatment Market Share by Players (2018-2023)
Table 19. Global Top Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Treatment as of 2022)
Table 20. Ranking of Global Top Influenza Treatment Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Influenza Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Influenza Treatment Product Solution and Service
Table 24. Date of Enter into Influenza Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Influenza Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Influenza Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Influenza Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Influenza Treatment Revenue Market Share by Type (2024-2029)
Table 30. Global Influenza Treatment Market Size by Channel (2018-2023) & (US$ Million)
Table 31. Global Influenza Treatment Revenue Market Share by Channel (2018-2023)
Table 32. Global Influenza Treatment Forecasted Market Size by Channel (2024-2029) & (US$ Million)
Table 33. Global Influenza Treatment Revenue Market Share by Channel (2024-2029)
Table 34. North America Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Influenza Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Influenza Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Influenza Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Influenza Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Influenza Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Influenza Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Influenza Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Influenza Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Influenza Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Influenza Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Influenza Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. Novartis AG Company Detail
Table 50. Novartis AG Business Overview
Table 51. Novartis AG Influenza Treatment Product
Table 52. Novartis AG Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 53. Novartis AG Recent Development
Table 54. Roche Holding Company Detail
Table 55. Roche Holding Business Overview
Table 56. Roche Holding Influenza Treatment Product
Table 57. Roche Holding Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 58. Roche Holding Recent Development
Table 59. BioCryst Pharmaceuticals Company Detail
Table 60. BioCryst Pharmaceuticals Business Overview
Table 61. BioCryst Pharmaceuticals Influenza Treatment Product
Table 62. BioCryst Pharmaceuticals Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 63. BioCryst Pharmaceuticals Recent Development
Table 64. Sanofi Company Detail
Table 65. Sanofi Business Overview
Table 66. Sanofi Influenza Treatment Product
Table 67. Sanofi Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 68. Sanofi Recent Development
Table 69. GSK plc. Company Detail
Table 70. GSK plc. Business Overview
Table 71. GSK plc. Influenza Treatment Product
Table 72. GSK plc. Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 73. GSK plc. Recent Development
Table 74. Viatris Inc. (Mylan) Company Detail
Table 75. Viatris Inc. (Mylan) Business Overview
Table 76. Viatris Inc. (Mylan) Influenza Treatment Product
Table 77. Viatris Inc. (Mylan) Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 78. Viatris Inc. (Mylan) Recent Development
Table 79. Teva Pharmaceutical Industries Ltd. Company Detail
Table 80. Teva Pharmaceutical Industries Ltd. Business Overview
Table 81. Teva Pharmaceutical Industries Ltd. Influenza Treatment Product
Table 82. Teva Pharmaceutical Industries Ltd. Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Ltd. Recent Development
Table 84. Daiichi Sankyo Company Detail
Table 85. Daiichi Sankyo Business Overview
Table 86. Daiichi Sankyo Influenza Treatment Product
Table 87. Daiichi Sankyo Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 88. Daiichi Sankyo Recent Development
Table 89. AstraZeneca Company Detail
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Influenza Treatment Product
Table 92. AstraZeneca Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. NATCO Pharma Limited Company Detail
Table 95. NATCO Pharma Limited Business Overview
Table 96. NATCO Pharma Limited Influenza Treatment Product
Table 97. NATCO Pharma Limited Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 98. NATCO Pharma Limited Recent Development
Table 99. Gilead Sciences Company Detail
Table 100. Gilead Sciences Business Overview
Table 101. Gilead Sciences Influenza Treatment Product
Table 102. Gilead Sciences Revenue in Influenza Treatment Business (2018-2023) & (US$ Million)
Table 103. Gilead Sciences Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Influenza Treatment Market Share by Type: 2022 VS 2029
Figure 3. Peramivir Features
Figure 4. Zanamivir Features
Figure 5. Baloxavir Marboxil Features
Figure 6. Oseltamivir Phosphate Features
Figure 7. Others Features
Figure 8. Global Influenza Treatment Market Size Comparison by Channel (2023-2029) & (US$ Million)
Figure 9. Global Influenza Treatment Market Share by Channel: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Influenza Treatment Report Years Considered
Figure 14. Global Influenza Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Influenza Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Influenza Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Influenza Treatment Market Share by Players in 2022
Figure 18. Global Top Influenza Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Influenza Treatment Revenue in 2022
Figure 20. North America Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Influenza Treatment Market Share by Country (2018-2029)
Figure 22. United States Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Influenza Treatment Market Share by Country (2018-2029)
Figure 26. Germany Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Influenza Treatment Market Share by Region (2018-2029)
Figure 34. China Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Influenza Treatment Market Share by Country (2018-2029)
Figure 42. Mexico Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Influenza Treatment Market Share by Country (2018-2029)
Figure 46. Turkey Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Influenza Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 49. Roche Holding Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 50. BioCryst Pharmaceuticals Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 52. GSK plc. Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 53. Viatris Inc. (Mylan) Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 54. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 55. Daiichi Sankyo Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 56. AstraZeneca Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 57. NATCO Pharma Limited Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 58. Gilead Sciences Revenue Growth Rate in Influenza Treatment Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit